03/27/2024
- Large advisory firm
8 14.29%
7 16.67%
SEC, Approved, 12/19/2003
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...
BarronsStocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...
BarronsStocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...
BarronsFund Type | Count | GAV |
---|---|---|
Hedge Fund | 6 | $647,896,107 |
Adviser | Hedge Fund | Liquidity Fund | Private Equity Fund | Real Estate Fund | Securitized Asset Fund | Venture Capital Fund | Other Fund | Total Private Fund GAV | AUM | # funds | |
---|---|---|---|---|---|---|---|---|---|---|---|
AR ASSET MANAGEMENT, INC. | 135.2m | - | - | - | - | - | - | 135.2m | 542.1m | 3 | |
FORT, L.P. | 85.1m | - | - | - | - | - | - | 85.1m | 358.9m | 2 | |
ENGLE CAPITAL MANAGEMENT, L.P. | 408.9m | - | - | - | - | - | - | 408.9m | 489.4m | 1 | |
LOGAN STONE | 552.3m | - | - | - | - | - | - | 552.3m | 805.4m | 2 | |
SHAH CAPITAL MANAGEMENT | 444.5m | - | - | - | - | - | - | 444.5m | 514.6m | 1 | |
ORIBEL CAPITAL MANAGEMENT, LP | 101.0m | - | - | - | - | - | - | 101.0m | 1.2b | 1 | |
INCOME PARTNERS ASSET MANAGEMENT (HK) LIMITED | 8.3m | - | - | - | - | - | - | 8.3m | 368.3m | 1 | |
SOLAS CAPITAL MANAGEMENT, LLC | 102.2m | - | - | - | - | - | - | 102.2m | 599.1m | 2 | |
RIVA RIDGE CAPITAL MANAGEMENT LP | 569.1m | - | - | - | - | - | - | 569.1m | 606.8m | 4 | |
KEENAN CAPITAL, LLC | 662.1m | - | - | - | - | - | - | 662.1m | 662.1m | 1 |
Stock Ticker | Stock Name | $ Position | % Position | $ Change | # Change |
---|---|---|---|---|---|
78464A870 | SPDR S&P BIOTECH ETF | $41,256,414 | 10.00% | 1.00% | 3.00% |
85916J409 | STEREOTAXIS INC | $24,898,608 | 6.00% | -30.00% | 0.00% |
N5749R100 | MERUS N V | $24,226,861 | 6.00% | 42.00% | 8.00% |
76155X100 | REVOLUTION MEDICINES INC | $19,866,606 | 5.00% | 20.00% | 0.00% |
23282W605 | CYTOKINETICS INC | $21,569,058 | 5.00% | -23.00% | 0.00% |
45166A102 | IDEAYA BIOSCIENCES INC | $14,823,898 | 4.00% | -24.00% | -5.00% |
09627Y109 | BLUEPRINT MEDICINES CORP | $11,291,356 | 3.00% | 11.00% | -2.00% |
04351P101 | ASCENDIS PHARMA A/S | $11,042,961 | 3.00% | -21.00% | -12.00% |
04963C209 | ATRICURE INC | $14,553,969 | 3.00% | 77.00% | 136.00% |
87164F105 | SYNDAX PHARMACEUTICALS INC | $13,489,729 | 3.00% | -14.00% | 0.00% |